NCT06121297: RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Sponsor: Cabaletta Bio. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, Lupus Nephritis